BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30522086)

  • 1. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
    Lambrakis K; French JK; Scott IA; Briffa T; Brieger D; Farkouh ME; White H; Chuang AM; Tiver K; Quinn S; Kaambwa B; Horsfall M; Morton E; Chew DP
    Am Heart J; 2019 Feb; 208():11-20. PubMed ID: 30522086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.
    Rocheleau S; Eng-Frost J; Lambrakis K; Khan E; Chiang B; Wattchow N; Steele S; Lorensini S; Lehman SJ; Papendick C; Chew DP
    Heart Lung Circ; 2023 Aug; 32(8):978-985. PubMed ID: 37225600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
    J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suspected ACS Patients Presenting With Myocardial Damage or a Type 2 Myocardial Infarction Have a Similar Late Mortality to Patients With a Type 1 Myocardial Infarction: A Report From the Australian and New Zealand 2012 SNAPSHOT ACS Study.
    Etaher A; Chew D; Redfern J; Briffa T; Ellis C; Hammett C; Lefkovits J; Elliott J; Cullen L; Brieger D; French JK
    Heart Lung Circ; 2017 Oct; 26(10):1051-1058. PubMed ID: 28139353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
    Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
    White K; Kinarivala M; Scott I
    BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
    Nestelberger T; Boeddinghaus J; Lopez-Ayala P; Kaier TE; Marber M; Gysin V; Koechlin L; Sanchez AY; Giménez MR; Wussler D; Walter JE; Strebel I; Zimmermann T; Glarner N; Miró Ò; Martin-Sanchez FJ; Zehnder T; Twerenbold R; Keller DI; Mueller C;
    JAMA Cardiol; 2021 Jul; 6(7):771-780. PubMed ID: 33881449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
    Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
    Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
    Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
    Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
    BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
    Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial.
    Morrow DA; Cannon CP; Rifai N; Frey MJ; Vicari R; Lakkis N; Robertson DH; Hille DA; DeLucca PT; DiBattiste PM; Demopoulos LA; Weintraub WS; Braunwald E;
    JAMA; 2001 Nov; 286(19):2405-12. PubMed ID: 11712935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
    Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
    Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute versus chronic myocardial injury and long-term outcomes.
    Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
    Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial.
    Ferencik M; Liu T; Mayrhofer T; Puchner SB; Lu MT; Maurovich-Horvat P; Pope JH; Truong QA; Udelson JE; Peacock WF; White CS; Woodard PK; Fleg JL; Nagurney JT; Januzzi JL; Hoffmann U
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1272-1281. PubMed ID: 26476506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the fourth universal definition of myocardial infarction in clinical practice.
    Mair J; Cullen L; Giannitsis E; Hammarsten O; Huber K; Jaffe A; Mills N; Möckel M; Müller C; Thygesen K; Lindahl B
    Biomarkers; 2020 Jun; 25(4):322-330. PubMed ID: 32362195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.